Close Menu

NEW YORK – Inivata said today that it has signed a distribution agreement with IPS Genomix to provide its InVisionFirst-Lung and InVisionSeq liquid biopsy tests to cancer patients and partners in the Middle East and Africa.

Under the agreement, IPS Genomix — a part of Integrated Pharma Solutions — will facilitate patient access through both insurers and in the private pay market in the United Arab Emirates, Qatar, Kuwait, Bahrain, Lebanon, Jordan, Egypt, and the Kingdom of Saudi Arabia.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.